<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
KROS
Keros Therapeutics
$
()


  • Keros Therapeutics initiated with bullish view at Oppenheimer, here's why

    6/24/2024 - 16:14pm
  • Keros Therapeutics appoints CEO Jasbir Seehra as Chair of Board

    6/17/2024 - 16:05pm
  • Keros Therapeutics to hold a corporate update conference call

    6/17/2024 - 07:50am
  • Keros Therapeutics presents data from Phase 2 RESTORE trial of elritercept

    6/17/2024 - 06:06am
  • Keros Therapeutics presents clinical data from elritercept program

    6/17/2024 - 06:04am
  • Keros Therapeutics to hold a corporate update conference call

    6/17/2024 - 04:55am
  • Keros Therapeutics to hold a corporate update conference call

    6/14/2024 - 16:29pm
  • Keros Therapeutics price target raised by $11 at Wells Fargo, here's why

    5/9/2024 - 06:47am
  • Keros Therapeutics reports Q1 EPS ($1.21), consensus ($1.35)

    5/8/2024 - 08:05am
  • Keros Therapeutics files automatic mixed securities shelf

    5/3/2024 - 08:03am
  • Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call

    4/4/2024 - 12:10pm
  • Morphic appoints Cooper as Chief Medical Officer

    3/19/2024 - 08:04am
  • Keros Therapeutics announces Fast Track designation for KER-050

    3/14/2024 - 08:11am
  • Keros Therapeutics initiated with a Not Rated at Goldman Sachs

    3/13/2024 - 05:39am
  • Keros Therapeutics price target raised by $17 at Wells Fargo, here's why

    2/29/2024 - 06:20am
dynamic_feed Breaking News